Fenebrutinib

CAS No.

1434048-34-6

MDL No.

N/A

C₃₇H₄₄N₈O₄

664.80

InChI Key

WNEODWDFDXWOLU-QHCPKHFHSA-N

Pack Size	Purity	Price	Availability	Action
-	-	On Request	On Request
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

On Request

Custom synthesis and bulk supply options are available upon request.

Product Information

Fenebrutinib is an orally available BTK inhibitor with antineoplastic potential. It inhibits BTK activity and blocks the activation of the B-cell antigen receptor (BCR) signaling pathway.

CAS No.	1434048-34-6
Product Name	Fenebrutinib

Biological Targets

BTK

Associated Conditions

multiple sclerosis·chronic progressive multiple sclerosis·urticaria·type II hypersensitivity reaction disease·systemic lupus erythematosus·

* The information provided here is compiled from public sources and is for reference only.

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Documentation

Fenebrutinib

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Related Articles

Bruton's tyrosine kinase inhibitors in the treatment of multiple sclerosis.

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Safety, Pharmacokinetics, and Pharmacodynamics in Healthy Volunteers Treated With GDC-0853, a Selective Reversible Bruton's Tyrosine Kinase Inhibitor.

Pyrrolo[2,3-d]pyrimidines active as Btk inhibitors.

Documentation

Similar Products

Rocbrutinib